These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 9589946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR.
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of beano on the tolerability and pharmacodynamics of acarbose.
    Lettieri JT, Dain B.
    Clin Ther; 1998 Aug; 20(3):497-504. PubMed ID: 9663365
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acarbose for diabetes mellitus.
    Med Lett Drugs Ther; 1996 Feb 02; 38(967):9-10. PubMed ID: 8559114
    [No Abstract] [Full Text] [Related]

  • 10. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F, Compagnucci P.
    Drug Saf; 1994 Dec 02; 11(6):432-44. PubMed ID: 7727053
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S, Turco S, Guarino G, Oliviero B, Rustici A, Torella R.
    Ann Ital Med Int; 1999 Dec 02; 14(1):7-14. PubMed ID: 10528419
    [Abstract] [Full Text] [Related]

  • 16. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
    Matsumura M, Monden T, Miyashita Y, Kawagoe Y, Shimizu H, Nakatani Y, Domeki N, Yanagi K, Ikeda S, Kasai K.
    Adv Ther; 2009 Jun 02; 26(6):660-6. PubMed ID: 19568704
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New, in Austria registered specialty drugs. Glucobay (acarbose)].
    Sturm M.
    Wien Klin Wochenschr; 1992 Jun 02; 104(11):329-36. PubMed ID: 1621396
    [No Abstract] [Full Text] [Related]

  • 19. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR, Lembcke B.
    Internist (Berl); 1991 Dec 02; 32(12):699-707. PubMed ID: 1823561
    [No Abstract] [Full Text] [Related]

  • 20. Acarbose: can it take a bite out of type 2 diabetes mellitus?
    Ponte CD.
    Ann Pharmacother; 1996 Nov 02; 30(11):1333-5. PubMed ID: 8913419
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.